Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

DARUMA: a gateway to fast and easy prediction of intrinsically disordered regions.

PeerJ. Computer science·2026
Same journal

Alzheimer's disease detection using a quantum deep neural network with Haralick feature extraction and simulated annealing optimization.

PeerJ. Computer science·2026
Same journal

Network anomaly detection using Deep Autoencoder and parallel Artificial Bee Colony algorithm-trained neural network.

PeerJ. Computer science·2026
Same journal

An anomaly detection model for multivariate time series with anomaly perception.

PeerJ. Computer science·2026
Same journal

Retraction: A wormhole attack detection method for tactical wireless sensor networks.

PeerJ. Computer science·2026
Same journal

Evaluation of mental disorder with prioritization of its type by utilizing the bipolar complex fuzzy decision-making approach based on Schweizer-Sklar prioritized aggregation operators.

PeerJ. Computer science·2026

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

954

Enhancing Alzheimer's disease classification through split federated learning and GANs for imbalanced datasets.

G Narayanee Nimeshika1, Subitha D1

  • 1School of Computer Science and Engineering, Vellore Institute of Technology, Chennai, Tamil Nadu, India.

Peerj. Computer Science
|December 9, 2024
PubMed
Summary

This study introduces a novel approach for Alzheimer's disease detection using split federated learning (SFL) and conditional generative adversarial networks (cGANs) to address data imbalance and privacy concerns in medical AI.

Keywords:
AlzheimerConditional generative adversarial networksData privacyDecentralizedImbalancedSplit federated learning

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

765

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

954
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

765

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Healthcare
  • Computational Neuroscience

Background:

  • Healthcare data imbalance and privacy concerns hinder accurate medical classification.
  • Existing models struggle with decentralized and imbalanced datasets for diseases like Alzheimer's.
  • Advanced technologies are crucial for improving diagnostic accuracy and patient care.

Purpose of the Study:

  • To develop a privacy-preserving medical classification model for Alzheimer's disease detection.
  • To address challenges of imbalanced datasets and data decentralization in medical AI.
  • To enhance the generalization capabilities of AI models in clinical settings.

Main Methods:

  • Utilized split federated learning (SFL) for decentralized model training without data sharing.
  • Integrated conditional generative adversarial networks (cGANs) to synthesize realistic data for minority classes.
  • Developed a hybrid approach combining SFL and cGANs for robust Alzheimer's disease classification.

Main Results:

  • Achieved approximately 83.54% accuracy in Alzheimer's disease classification.
  • Demonstrated effective learning from decentralized and imbalanced medical datasets.
  • Successfully preserved patient data privacy through the federated learning framework.

Conclusions:

  • The proposed SFL and cGANs model effectively addresses data privacy and imbalance in medical classification.
  • This approach enhances diagnostic capabilities for Alzheimer's disease, improving potential patient outcomes.
  • The methodology offers a scalable solution for developing AI in healthcare while respecting data protection regulations.